Author

admin

Browsing

Right place, right time, right geology: Graham Arvidson believes Australia has a unique opportunity to build a world-class vanadium battery storage and circular value chain on the back of a 50-year resource in arguably the world’s best mining jurisdiction.

Arvidson, who had a front-row view of the explosive growth in Western Australia’s lithium industry over the past decade, heads Australian Vanadium, touted by some as the company most likely to become the world’s next large-scale primary vanadium producer.

The lithium space is flat now amid low prices but it spawned a A$15 billion lithium major (Pilbara Minerals; currently worth about $8.7 billion) and broader WA battery-grade material supply base in the past decade. State lithium exports climbed from sub-$6 billion in 2015-2016 to more than $18b last year.

“I’ve worked in most of the lithium mines here in WA and if you roll back time to 2016 most people couldn’t spell lithium,” says Arvidson, an IMARC 2024 Mining Spotlight speaker and lead on a feature panel discussion: What does a future made in Australia mean for mining?
“We would have sat across a table like we are right now having a conversation about price growth projections and you’d have had one party saying 10% growth and maybe someone talking about 200% growth. And the truth is, it’s been more extreme than that.”

The comparison highlights the difficulties nailing supply and demand, and pricing, predictions in such turbulent times for global energy, transport and manufacturing. It also points to an increasing market appetite for funding and advancing world-class projects with the right cost and risk settings where the long-term price signals are favourable, as with lithium.

Australian Vanadium’s managing director sees tailwinds building behind the company’s cornerstone WA project as vanadium’s long-term demand and price links to steel are transcended by the metal’s use in long-duration energy storage linked to renewable power and a multitude of industrial and societal use cases.

“Australian Vanadium aspires to manufacture vanadium flow batteries and is one of the few companies developing a grid-scale battery supply chain in Australia,” Perth investment firm Shaw and Partners said this month.
“The Australian Energy Market Operator [AEMO] forecasts that the National Electricity Market will quickly follow the US and need 19GW of storage capacity by 2030, rising to 43GW in 2040 and 56GW in 2050.
“Current storage capacity is just 6GW.”

Shaw says battery energy system storage is the fastest growing battery demand market in the US as that market matures and duration increases.

“The operating capacity of battery storage in the US grew by 7.9GW in 2023, bringing the country’s total cumulative installed base to 17GW. In more precise terms, there was 7881MW of new storage installations and 20,609MWh of new storage capacity deployed over the past 12 months.
“In 2024, battery storage capacity will grow 89%, or a further 14.3GW, according to the US Energy Information Administration, with most of that in California and Texas. Twelve US States now have grid energy storage targets, such as 15GW in California by 2032 and 6GW in New York by 2030.”

Meanwhile, costs per MWh have fallen 73% over the past 10 years and are expected to dip further as the industry scales.

Which, of course, is already happening in China.

Arvidson says China added more than 25GW hours per annum of vanadium flow battery (VFB) and vanadium electrolyte manufacturing capacity last year to support the rollout of VFB storage.

“To put that into context, that equates to 207,690 tonnes of annual vanadium demand,” he says.

Australian Vanadium aims to produce 11,200t per annum, roughly 5% of the Chinese gigafactory demand added in 2023, via the US$435 million project it outlined in a 2022 feasibility study. It is working on an optimised FS after completing a A$217m merger with Gabanintha project neighbour Technology Metals Australia earlier this year.

The merger consolidated their adjoining projects across the same orebody to give Australian Vanadium an updated mineral resource estimate of 395 million tonnes grading 0.77% V2O5, including a higher-grade domain of 173.2Mt grading 1.09%, and more options for lower-cost early extraction.

Vanadium’s use in batteries has grown from 1% of the market two years ago to more than 10% now.

“We don’t have them [vanadium redox flow batteries] in Australia at scale yet but China’s building them at incredible scale,” Arvidson says.
“In terms of actual units of vanadium most of the growth is in China because they’re installing and commissioning massive vanadium flow batteries – gigawatt-hour scale – but they’re also, in lockstep, then announcing all of the manufacturing base beside it. So, really large electrolyte production facilities, really large battery manufacturing plants. It’s a similar playbook in vanadium flow batteries to what they did with lithium-ion batteries.
“Some reports have the battery energy storage market [cumulative energy storage installations] going beyond the terawatt-hour mark globally before 2030; the question is, how much of it is going to be longer duration technology? Even if you take a small slice of that, it means vanadium has to double, triple, quadruple or more in terms of the market size.
“And that’s our thesis. We’ve got a tier one asset and we not only want to produce vanadium, we want to participate in that value chain because it’s quite a simple, elegant supply chain. Unlike with lithium, you don’t need nickel, cobalt, manganese, etc. You just need vanadium.
“The electrochemical machine that is a flow battery is a very simple device.
“It’s not farfetched to think that entire supply chain, not including the vanadium, is very easily scalable from standard industrial components. You don’t need pre-precursor cathode active materials … and you don’t need packets and assembly and everything else. You just need vanadium and electrolyte.
“One thing that China can’t impact is that in Australia we can be globally competitive in producing vanadium oxides and converting that to electrolyte. Vanadium oxides being globally competitive is a function of geology mostly and we have really good geology here.
“We have a 50-year mine life with very consistent geology. So the quantity and quality of vanadium oxides is in our control and it’s uniquely better than a lot of players out there because we have a VTM [vanadiferous titanomagnetite] deposit with very consistent geometallurgy. We can over 50 years produce a 99.5% purity V205, which is excellent for making electrolytes.
“Our C1 cost will be US$4.40 a pound, based on the [2022] BFS. When you convert to electrolyte, which we’re already doing here cost-effectively, the electrolyte with the oxides in it is 60%-plus of the value of the battery. So, 60% of the value of the batteries just by making the electrolyte will remain competitively advantageous if you can build out the production, which is what our core mission is.
“Our belief is that you can at least assemble the batteries locally.
“Step one is the lower risk entry point where you import the components – tanks, pumps, stacks, valves, instruments – all the stuff that we have all the trade skills to build and assemble.
“The next step beyond that, if you want to move beyond that, and we think it can become cost competitive, is more of an automated production system. In that scenario you’re probably importing robotically made stacks from China or Japan.
“To get there you need scale, which China has. But can you establish a competitive industry here? Our current thinking is absolutely. At a minimum, you’ve got 60% local content with the vanadium alone.
“If you look at lithium the vast majority of the lithium we export is spodumene. Over 90% of the value add is done overseas and most of that’s in China, typically. And then we buy back gigawatt hours of lithium-ion batteries.
“I think as long as it’s economically compelling, which vanadium flow batteries are for long duration energy storage, why would we import Chinese lithium-ion batteries when we can build batteries locally to provide the lowest levelised cost of storage?
“The cost of delivering power from these batteries is lower than lithium-ion. The batteries last 50 years. They can cycle infinite times. They don’t catch fire. And they don’t degrade.
“The true strength of vanadium flow batteries is that they don’t necessarily replace lithium ion, they augment it. They are just much, much better and more economic at long duration storage.
“So I think there’s a really compelling story here. Why isn’t it happening already? It’s just because nowhere in Australia yet are we tendering eight-hour batteries, but it is coming.
“The rest of the world is making that long-duration transition. They need something to do that.
“In places like Australia, pumped hydro is not working out too well. In WA there’s literally nowhere to do it.
“But you need lots of different technologies deploying to get this transition to happen.
“AEMO is saying the medium-to-long-duration storage capacity will grow to 120GWhr by 2040; growing at 6GWhr per annum. This is the long-duration category that lithium ion is not good at.
“Again, to put it in context, our mine would do about 1.1GWhr-equivalent battery capacity in terms of vanadium units. Even if all of our vanadium units just went into Australian batteries we’re still only one-sixth of the total Australian growth.
“If there was a perfect jurisdiction in the world for me to kickstart this, it’s WA. If there is an incredibly economic way to use solar it is to put 12-hour batteries with it.
“And the most economic, recyclable, circular economy, non-flammable local content for that battery is vanadium.”

Hear more from

Graham Arvidson
Chief Executive Officer
Australian Vanadium

Source

This post appeared first on investingnews.com

Investor Insight

A Bloomberg Intelligence report shows the plant-based market could make up to 7.7 percent of the global protein market by 2030, with a value of over $235 billion, up from US$42.7 billion in 2020. Wide Open Agriculture’s value proposition combines technology with the benefits of lupin to create a range of powerful and sustainable plant-based protein products that can leverage a booming market.

Overview

Wide Open Agriculture (ASX:WOA,FRA:2WO) is an ag-tech company based in Australia, focusing on the next generation of plant protein ingredients for food and drink manufacturers globally. The company is focused on harnessing the benefits of lupin as a sustainable and powerful source of protein, offering it as an alternative to traditional plant-based protein products such as soy and pea.

Lupin is increasingly recognized as a valuable plant-based superfood, recognized for their high protein and dietary fibre content, making them a valuable addition to human nutrition. On the sustainability front, lupins have the ability to enrich soil fertility, thereby supporting more environmentally friendly agricultural practices. Their role in crop rotation and their nitrogen-fixing abilities contribute to reduced reliance on synthetic fertilizers, promoting better land management and sustainability. Using lupin-based protein ingredients helps improve manufacturers’ environmental credentials, as well.

Key to WOA’s value proposition is its patented ag-tech process that turns lupins into a superfood, producing a protein ingredient that enables food manufacturers to improve and replace traditional ingredients by eliminating the need for sugars and other artificial additives. WOA’s Buntine Protein is a breakthrough product, offering the most neutral-tasting plant-based protein in the market and allowing food manufacturers to create ‘clean label’ food and drink products. Traditional soy-based and pea-based ingredients often require additional ingredients, like sugars and additives, to make them palatable to consumers.

Company Highlights

Wide Open Agriculture (WOA) is focused on developing cleaner, better quality and more functional alternatives to current plant-based protein sources.WOA plans to leverage its patented agritech process to create protein-rich, lupin-based products and ingredients that do not contain additives like sweeteners, gums and stabilizers traditionally used with conventional soy-based or pea-based proteins.Overall, the products created by WOA are cleaner tasting and more functional. The company’s main goal remains to bring its lupin protein isolate, called Buntine Protein® to market as quickly and cost effectively as possible. Over the next six to nine months, WOA will work with food companies to get products to market and ramp up production at its world class manufacturing facility in Germany.

Key Products and Process

Through IP licenced from Curtin University in 2020, WOA has worked towards commercializing the IP at scale, combining it with the company’s deep knowledge of lupin protein extraction and processing. As a result, WOA has developed a range of products that provide a healthier, more sustainable alternative to traditional soy-based or pea-based protein products.

WOA opened a pilot production plant early in 2023 to produce its eco-friendly Buntine Protein. The technology targets a constituent part of lupin that allows it to increase the proteins’ ability to blend and mix with other food ingredients.

In October 2023, WOA purchased European lupin protein-isolate producer Prolupin GmbH. The $4.3-million acquisition gives WOA immediate access to commercial-scale manufacturing capacity. Having a foothold in Germany will also help WOA get its Buntine Protein to a wider market. The sale includes Prolupin’s German manufacturing facility and the patents to produce the Prolupin protein isolate.

The German facility has the capacity to produce 500 tons per year of lupin-protein concentrate with the ability to expand production to 1,000 tons per year, with an investment of $3 to $5 million within the next one to two years. Prolupin’s technology will also help diversify and enhance WOA’s lupin-product catalogue, with the capability to produce protein-rich lupin isolates, a protein concentrate in wet form, and a lupin oil.

WOA’s proprietary lupin-based protein ingredients have been successfully integrated into third-party consumer products in Australia and the US. CHONK vegan cookies, sold in Australia, is a gluten-free, egg-free, soy-free and dairy-free treat that uses Buntine Protein as an ingredient. In the US, WOA’s Prolupin isolate LP90 has been integrated into Superitalia’s Instant Superfood Cappuccino brand.

After an extensive R&D program, WOA’s new lupin fibre product, designed for the dietary fibre market projected to reach $16.3 billion by 2032, is now also ready for commercialization.

This year, the company plans to: 1) increase sales by working with international food manufacturers and brands; and 2) monetize co-products like lupin-oil and lupin fibre.

Management Team

Yaxi Zhan – Non-executive Director and Chairperson

Yaxi Zhan is an experienced executive with over 17 years of experience across startups, large-scale mining operations and ASX-listed companies. With strong connections in the Australian and Chinese business communities, Zhan is recognised for her business acumen and efficiency across diverse business and cultural environments. She is the founder and former managing director of Accelerate Resources Limited (ASX:AX8).

Anthony (Maz) Maslin – Non-executive Director

Anthony Maslin is an entrepreneur and social change visionary, driven by bringing new meaning and hope to environmental and community projects.

Joanne Ford – Non-executive Director

Joanne Ford is an experienced director and executive, with over 30 years of experience in ASX and international listed groups, start-ups and not-for-profit companies.

Beverley Nichols – Interim Chief Financial Officer

Beverley Nichols is a qualified certified practicing accountant with more than 15 years of experience, serving as the CFO of ASX listed companies across industries. Her extensive experience in financial reporting, regulatory compliance, and finance management will enhance the company’s financial operations and support its strategic objectives.

Merilyn Elson – Product Strategy and Innovation Manager

Merilyn Elson’s background is in the fast-moving consumer goods industry, where she worked for a WA family-owned food manufacturer for over 30 years.

Hayder Al-Ali – Senior Food Scientist

During Hayder AL-Ali’s PhD program, he worked extensively on optimizing lupin protein extractability, techno-functionality and palatability.

This post appeared first on investingnews.com

Chilean state-run copper giant Codelco has made a US$500 million bid to acquire a 10 percent stake in the Quebrada Blanca mine, operated by Teck Resources (TSX:TECK.A,TSX:TECK.B,NYSE:TECK).

According to a Tuesday (September 3) Bloomberg report, the offer, directed to fellow state entity Empresa Nacional de Minería (Enami), is currently under consideration by Enami’s board. The move is part of Codelco’s strategy to sustain its position as the world’s leading copper supplier amid declining production levels.

Enami’s stake in Quebrada Blanca represents a carried interest, meaning it is not responsible for the mine’s capital expenditures. The sale, if approved, would provide Enami with funds to address financial challenges.

The company has faced consistent losses in recent years due to its role in processing minerals for small-scale miners in Chile. The infusion of US$500 million could help reduce its debt burden while limiting the necessity for public funding.

Quebrada Blanca, located in Northern Chile, is a significant copper mine that is primarily owned by Teck Resources (60 percent), with Japan’s Sumitomo Metal Mining (TSE:5713) holding a 30 percent interest.

As mentioned, acquiring Enami’s stake in Quebrada Blanca would help Codelco stabilize its copper production, which dropped to its lowest level in 25 years in 2023. It would also help the company retain its title as the world’s top producer.

However, the proposed purchase is not without obstacles. The Chilean National Mining Society (Sonami), which holds a position on Enami’s 10 member board, has voiced concerns about the process.

Sonami believes any sale of the Quebrada Blanca stake should be conducted via an open and competitive bidding process, not a direct transaction with Codelco — potentially delaying or complicating the approval process for the bid.

Regardless, the move comes at a critical time for Chile, as the nation faces challenges in maintaining its status as the top global copper producer. Declining ore grades, aging infrastructure and competition from other copper-producing countries have all combined to put pressure on the state’s output.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

(TheNewswire)

Drilling indicates the presence of a Carbonate Replacement (‘CRD’) style system at Tim

2,252 metres drilled in six holes

Drill is currently moving from Tim to the Haldane Property

Vancouver, BC TheNewswire – September 4, 2024 Silver North Resources Ltd. (TSX-V: SNAG, OTCQB: TARSF) ‘ Silver North ‘ or the ‘ Company ‘) is pleased to announce that the 2024 drilling program at the Tim Property has now been completed and the drill is being demobilized from site. The Tim Property is under option to, and operated by, Coeur Mining, Inc. (‘Coeur’ NYSE-CDE), which is funding the 2024 program. A total of 2,252 metres were drilled in six holes in the program. The drill is now enroute to Silver North’s wholly-owned Haldane Property in the historic Keno Hill Silver District and the Company’s technical team is on site.

‘We would like to thank the Coeur Silvertip team,’ stated Jason Weber, P.Geo., President and CEO of Silver North. ‘Coeur has exceeded expectations on every program they have conducted at Tim. The late addition of two airborne geophysical surveys to augment this year’s drilling is an example of the big-picture approach they are taking at Tim to identify how it fits into the regional CRD setting. We eagerly await the receipt of analytical results this fall.’

As outlined in Silver North’s update of August 19, 2024, drill core observations from the first three holes of the program include diagnostic features that are commonly associated with significant CRD mineralization and have been observed at the Silvertip deposits. Such characteristics include fugitive calcite veining that fluoresces in UV light (displaying the classic ‘barbeque’ pink and orange fluorescence) and re-crystallization of the host limestones.

The 2024 program is conducted under the direction of Coeur’s exploration team based at Silvertip, under the terms of an option agreement granting Coeur the right to earn a 51% interest in the property by completing a minimum of $3.15 million in additional exploration expenditures and making additional cash payments to Silver North totalling $275,000 by December 31, 2026. Coeur can bring its interest to 80% by making additional cash payments of $100,000 per year in 2027 and 2028, completing a positive feasibility study and informing Silver North of its intention to develop a mine at Tim by December 16, 2028. Under this agreement, Coeur must fund a minimum $700,000 program in 2024. Tim is road accessible via 25 km of 4 x 4 access off the Silvertip Mine Road.

About Silver North Resources Ltd.

Silver North’s primary assets are its 100% owned Haldane silver project (next to Hecla Mining Inc.’s Keno Hill Mine project) and the Tim silver project (under option to Coeur Mining, Inc.).

The Company is listed on the TSX Venture Exchange under the symbol ‘SNAG’, trades on the OTCQB market in the United States under the symbol ‘TARSF’, and under the symbol ‘I90’ on the Frankfurt Stock Exchange.

Mr. Jason Weber, P.Geo., President and CEO of Silver North Resources Ltd. is a Qualified Person as defined by National Instrument 43-101. Mr. Weber supervised the preparation of the technical information contained in this release.

For further information, contact:

Jason Weber, President and CEO

Sandrine Lam, Shareholder Communications

Tel:  (604) 807-7217

Fax: (888) 889-4874

To learn more visit: www.silvernorthres.com

X: https://x.com/SilverNorthRes

LinkedIn: https://

Copyright (c) 2024 TheNewswire – All rights reserved.

News Provided by TheNewsWire via QuoteMedia

This post appeared first on investingnews.com

G Mining Ventures (TSX:GMIN,OTC Pink:GMINF) announced on Tuesday (September 3) that it has started commercial production at its Brazil-based Tocantinzinho gold mine both on time and on budget.

Tocantinzinho, which has been under development since September 2022, is now operational, and is expected to produce an average of 174,700 ounces of gold annually over its 10.5 year lifespan.

For the first five years of production, average yearly gold output will be higher at 196,200 ounces.

Tocantinzinho’s transition to commercial production was confirmed after the mill operated at 76 percent of its nameplate throughput capacity for 30 consecutive days in August. During this period, the mine processed over 300,000 metric tons of ore at a recovery rate of 88 percent, meeting the criteria set for commercial production.

The company is now ramping up operations, and is aiming to achieve full nameplate throughput by Q1 2025.

Louis-Pierre Gignac, CEO of G Mining Ventures, expressed satisfaction with the progress seen so far at Tocantinzinho, highlighting the efforts of the team involved in bringing the mine to this stage.

“This achievement is the culmination of 5.8 million person-hours focused on building, testing and ramping up production at Brazil’s newest major gold mine,” he said in the company’s press release. “With this accomplishment behind us, we remain committed to enhancing plant performance and achieving our production and cost KPIs.’

The construction and commissioning phases were completed with a focus on safety and efficiency, allowing work at the asset to remain within the projected timeline since construction began in H2 2022.

G Mining Ventures intends for Tocantinzinho to be a cornerstone asset, and sees it benefiting from today’s high gold price. The company will provide annual guidance for the operation in January 2025.

The ramp-up phase, which will continue through the second half of 2024, will be key for optimizing plant operations and achieving the projected recovery rate of 90 recent over the life of the mine.

G Mining Ventures’ future milestones include the release of a preliminary economic assessment for its Oko West project in Guyana; exploration results are also pending from Oko West as well as Tocantinzinho.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Goldman Sachs (NYSE:GS) has revised its copper price forecast, significantly lowering its 2025 estimate due to weakening demand from China, a major consumer of the metal.

The American investment bank now anticipates that copper prices will average US$10,100 per metric ton next year, a sharp reduction from its previous forecast of US$15,000.

According to Bloomberg, the US$15,000 prediction came from former analysts Jeffrey Currie and Nicholas Snowdon, while the new outlook was outlined in a note by analysts including Samantha Dart and Daan Struyven.

Explaining their thoughts on China, Dart and Struyven point to its ongoing economic challenges, including a persistent downturn in the property sector and slower-than-expected recovery in manufacturing and exports.

As copper demand from the Asian nation has slowed, inventories of the red metal have risen.

Goldman Sachs has also adjusted its price forecasts for other commodities.

It is now estimating an aluminum price of US$2,540 per metric ton, down from US$2,850. The bank is holding to its bearish outlook on iron ore and nickel, reflecting the broader trend of weaker demand in key markets.

‘Softer-than-expected China commodity demand, as well as downside risks to China’s forward economic outlook, lead us to a more selective, less constructive tactical view of commodities,’ the analysts said.

China’s economic growth is struggling to meet the government’s 5 percent annual target, primarily due to a surplus of raw material inventories that is unlikely to clear soon due to softening demand.

Goldman Sachs remains optimistic about gold, maintaining a target price of US$2,700 per ounce for early 2025. The bank cites increased interest from managed money players in the west and continued demand from central banks as key factors supporting its positive outlook. Interest rate cuts from the US Federal Reserve are also seen helping gold.

Major miners involved in copper and aluminum production saw share price declines on the news, including Freeport-McMoRan (NYSE:FCX), BHP (LSE:BHP,ASX:BHP,NYSE:BHP) and Rio Tinto (ASX:RIO,NYSE:RIO,LSE:RIO).

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Siren Gold Limited (ASX: SNG) (Siren or the Company) is pleased to provide an update on its Auld Creek Project in Reefton.

Highlights

Three metallurgical samples from Auld Creek were tested for gold and antimony recoveries at ALS in Perth.All three samples gave excellent gold flotation recoveries ranging from 95-98%.Antimony recoveries are modest (around 64-90%) using copper sulphate as an activator.Changing from copper sulphate to lead nitrate as an activator boosted antimony recovery from 71% to 97%.The rougher concentrate grade for the lead nitrate test was 44.8g/t Au and 13.2% Sb. Cleaning tests are expected to enhance these grades further.Additional optimisation work using lead nitrate as an activator is expected to commence in Q4 of CY2024.

Siren Managing Director and CEO, Victor Rajasooriar commented:

” These are excellent results as we progress our Reefton gold and antimony projects into the future. The commodity pricing outlooks for both metals are excellent and the introduction of antimony as a critical mineral brings additional potential benefits to New Zealand. We are now in the final stages of completing our Auld Creek mineral resource calculations following the drilling program earlier this year and expect to have that completed in the coming weeks. Concurrently, additional metallurgical testwork will be carried out to optimise the recoveries of antimony at Auld Creek.”

Background

Three metallurgical samples were collected from Auld Creek diamond core within the Fraternal Shoot to test for both gold and antimony recoveries into a flotation concentrate. The samples were delivered to ALS Perth in May 2024 for a range of metallurgical tests under the supervision of metallurgist Graham Brock (Leo Consulting Ltd).

AC001 was collected from the top of the shoot that has little or no antimony. AC002 was collected from the middle of the shoot with high grade gold and antimony and AC003 was collected to represent the average resource gold and antimony grades (Table 1 and Figure 1).

AC001 Flotation Tests

Three tests were conducted on the low-grade antimony sample AC001. Test 1 was a standard kinetic rougher test giving a 95.8% recovery of the gold into the rougher concentrate at a grade of 51.2 g/t Au. Antimony recovery was also high, but the head grade was low at 0.05%.

Tests 2 and 3 were kinetic cleaner tests; Test 2 had no regrind and Test 3 included a regrind step. Test 2 produced a high-grade concentrate assaying 120.6g/t Au and Test 3 produced a grade of 136.6g/t Au. Gold recoveries were 91.9% in Test 2 and 87.7% in Test 3.

In summary, if this material was fed to a flotation concentrator 6% by weight would go to a 51g/t Au concentrate at 95.8% gold recovery. To reduce transport costs a cleaner circuit could be introduced such that for a small loss of recovery only 2.6% by weight at a grade of 120g/t Au could be produced. Testing showed little benefit in the regrind step.

Click here for the full ASX Release

This post appeared first on investingnews.com

True North Copper Limited (ASX:TNC) (True North, TNC or the Company) is pleased to announce results from a systematic rock chip sampling campaign at the Aquila and Ivena North prospects, part of its 100% owned Mt Oxide Project, located 140km north of Mt Isa in Queensland.

HIGHLIGHTS

Assay results received from a successful rock chip sampling program at the Aquila and Ivena North prospects, part of TNC’s 100% owned Mt Oxide Project in Queensland.Aquila and Ivena North are both part of the larger Dorman Fault Mineral System, a +10km long trend that hosts the Vero Cu-Ag-Co Resource and the Camp Gossans Prospect.At Aquila, sampling has highlighted six zones of anomalous Cu, Co & As associated with multiple gossanous breccia structures up to 30m wide.Aquila B Trend: +180m long and +30m wide Cu +/- Co-As-Ag within a 440m long fault breccia with visible copper oxide mineralisation. The trend includes rock chip channels returning 3.6m @ 0.49% Cu with a peak assay of 0.94% Cu.Aquila A Trend: +20m long and up to 12m wide Cu-As-Sb anomalous zone within +210m strike of hematite altered hydrothermal breccias, returning up to 0.05% Cu and 12.7g/t Ag and anomalous pathfinders.Aquila D Trend: +100m long and up to 4m wide Cu-Co trend associated with a historical prospecting pit with strong copper oxide mineralisation, and a peak assay of 0.87% Cu.At Ivena North, sampling has identified Cu, Co & As trends within two geochemically anomalous zones from multiple gossanous breccia structures that are up to 25m wide.Ivena North A Trend – +130m long and up to 15m wide Cu-Co-As trend within a +580m strike of hydrothermal breccia and gossans that returned assays up to 1.38% Cu and anomalous As +/- Ag-Sb-Bi-Mo.A combined 680m strike length of mapped hematite silica gossans remains under-sampled between the Aquila and Mt Gordon Prospects.Rock chip results will be integrated with ongoing mapping and results from the Queensland Government-funded MIMDAS IP and MT survey, which is currently underway along the Dorman Fault Mineral System.

The rock chip sampling program has successfully identified new broad zones of strongly anomalous copper and pathfinder elements. The copper grades and pathfinder anomalism returned in the samples are at levels consistent with other outcropping leached gossans associated with historic drill discoveries in the region.

The Ivena North and Aquila prospects are located along strike northwest of the high-grade Vero Cu-Ag-Co resource (Vero). Both prospects are high priority exploration targets for TNC, with a MIMDAS Induced Polarisation (IP) and Magnetotellurics (MT) geophysical survey continuing at Mt Oxide to test for geophysical anomalies coincident with outcropping geochemically anomalous gossans1, 3.

COMMENT

True North Copper’s Managing Director, Bevan Jones said:

“Our exploration team has been working hard to systematically map and sample the +10km Dorman fault trend at Mt Oxide. Multiple gossans have been identified, and rock chip results from the gossans are revealing large areas of wider and stronger mineralisation on which to focus our future exploration work, including the ongoing MIMDAS geophysical survey.

We are also remobilising the on-ground team to systematically collect additional rock chip samples over the newly discovered Black Marlin and Rhea structures. Further geophysical results are filtering through, and updates will be released soon. We are potentially building a significant district at Mt Oxide with multiple high priority targets which have never been drilled. Our next steps include prioritisation of these targets, designing and planning upcoming drill programs, and securing the necessary permits for on-ground access.”

Summary of Results

During Q4 CY23, TNC’s Discovery Team initiated a prospectivity analysis of the Dorman Fault Mineral System, host to the Vero Cu-Ag-Co Resource (Vero) (15.03Mt @ 1.46% Cu and 10.59g/t Ag M, I & I, refer Table 1)4. Geological and structural mapping delineated a +10km highly prospective corridor of intermittently outcropping gossanous and silica breccias with no drilling, surface sampling or effective geophysics. Since completion of this work, TNC has collected 388 rock chip samples, including 243.5m of rock chip channel samples at the Ivena North and Aquila Prospects where TNC is currently acquiring MIMDAS IP and MT as part of its Queensland Government Collaborative Exploration Initiative (CEI) grant3.

Analysis of the assay results has highlighted eight high priority geochemically anomalous zones within the larger, structurally complex footprint at both prospects with two of these zones remaining open to the north. These anomalies have similar pathfinder geochemical signatures and are within the order of magnitude of the results from Camp Gossans4 south of Vero, which are considered analogous to the leached gossan outcrops at the Esperanza South deposit4.

Click here for the full ASX Release

This post appeared first on investingnews.com

As the percentage of the global population over 65 continues to increase, the popularity of anti-aging stocks is rising in tandem thanks to advancements in technology and a growing body of research on human longevity.

The desire to increase life quality and expectancy is what drives the top anti-aging stocks in the life science space as they pursue technologies and therapies aimed at slowing the aging process and preserving health. Age-related diseases are a main focus of this sector, including cancers, cardiovascular diseases, Alzheimer’s disease, Parkinson’s disease and osteoarthritis.

Analysts are expecting the longevity and anti-aging therapy sector to develop into a multibillion-dollar industry in the coming years. It had an estimated market value of US$600 million in 2023, and Verified Market Reports is projecting that value to increase at a compound annual growth rate of 18 percent through 2030 to reach US$3.6 billion.

For those considering which anti-aging stocks to invest in, below is a brief overview of five NASDAQ-listed stocks with market caps between US$50 million and US$500 million. NYSE companies were considered but didn’t make the cut.

All company figures were current as of August 9, 2024.

1. GRAIL (NASDAQ:GRAL)

Company Profile

Market cap: US$477.225 million

California-based GRAIL is focused on the area of precision oncology through early cancer detection technology. The healthcare company has developed a methylation-based multi-cancer early detection platform known as Galleri. It incorporates next-generation sequencing and large-scale clinical studies with machine learning, software and automation to detect and identify multiple types of cancer and monitor for reoccurrence.

This year, GRAIL launched a three-year study to evaluate the clinical impact of the Galleri multi-cancer early detection test in the Medicare population by assessing the safety of the test and any reduction in diagnosed stage IV cancers in a population of about 50,000 people receiving the test annually compared to a group not receiving it. The US Food and Drug Administration (FDA) has granted GRAIL an Investigational Device Exemption for the trial.

2. Verve Therapeutics (NASDAQ:VERV)

Company Profile

Market cap: US$394.35 million

Clinical-stage Verve Therapeutics is developing single-course gene-editing treatments for lowering LDL cholesterol (the ‘bad’ cholesterol), which is closely linked to atherosclerotic cardiovascular diseases — the leading cause of death globally.

In early August, the company provided an update on its clinical progress in 2024 and future catalysts over the next year.

“Our Heart-2 Phase 1b clinical trial of VERVE-102 continues to progress as we focus on enrolling patients and expanding the trial’s geographic footprint, highlighted by our recent regulatory clearance in Australia,’ stated Verve co-founder and CEO Sekar Kathiresan.

‘We look forward to providing initial data from the Heart-2 clinical trial in the first half of 2025. In addition, we are on track to initiate the Phase 1b clinical trial for our ANGPTL3 product candidate, VERVE-201, in the second half of this year, and we continue to advance our early-stage programs, including one targeting the LPA gene.”

3. Anika Therapeutics (NASDAQ:ANIK)

Company Profile

Market cap: US$372.474 million

Headquartered in Boston, Massachusetts, Anika Therapeutics is focused on advancements in early intervention orthopedic care and joint preservation. The company is developing minimally invasive products that leverage its expertise in hyaluronic acid and implants to restore active living for patients. Its target areas include age-related and injury-related fields such as osteoarthritis pain management, regenerative solutions, sports medicine and arthrosurface joint implants.

In its Q2 2024 financial report, Anika highlighted strong revenue growth of 17 percent in the first half of the year for international sales in its osteoarthritis pain management division.

“OA Pain Management remains a strong, foundational element of our business and represents a key aspect of total company profitability,” Cheryl R. Blanchard, Anika Therapeutics president and CEO, stated in the release.

4. Ocugen (NASDAQ:OCGN)

Company Profile

Market cap: US$374.22 million

Pennsylvania’s Ocugen is working to bring to market gene and cell therapies for the treatment of ocular and orthopedic conditions.

Its product pipeline includes OCU400, which received orphan drug designation. It is currently in Phase 3 clinical trials for treatment of retinitis pigmentosa, and is being tested on a group of patients with RHO mutations and a group with other related gene-mutations.

It is also developing OCU410, a modifier gene therapy targeting geographic atrophy, an advanced stage of dry age-related macular degeneration. It leverages a nuclear hormone receptor gene called RORA and is a single sub-retinal injection that has the potential to be a one-time therapy for life. According to the company, current treatment options require 6 to 12 doses per year.

In the first half of 2024, Ocugen made significant progress in its Phase 2 OCU410 clinical trial, and preliminary safety and efficacy data is expected later this year.

Another therapy in Ocugen’s pipeline is NEOCART, a regenerative cell therapy for the treatment of articular cartilage defects in the knee that can lead to osteoarthritis. The company intends to launch the Phase 3 trial for NEOCART once it can secure adequate funding.

5. Lyell Immunopharma (NASDAQ:LYEL)

Company Profile

Market cap: US$348.164 million

San Francisco-based Lyell Immunopharma is advancing a diverse pipeline of CAR T-cell reprogramming therapies targeting solid tumors. The clinical-stage company’s pipeline includes product candidates entering Phase 1 studies in various indications including triple-negative breast cancer, non-small cell lung cancer, ovarian cancer, endometrial cancer, melanoma and colorectal cancer.

In its Q2 2024 report, Lyell provided an update on its Phase 1 LYL119, for which the FDA recently gave investigational new drug clearance. The trial is studying the drug candidate’s use for treating patients with ROR1-positive, platinum-resistant ovarian cancer or endometrial cancer. A report on the initial clinical data is expected in H2 2025.

FAQs for longevity and anti-aging

Will we be able to reverse aging in the future?

While research on reverse aging is growing, a recent article in Popular Science throws cold water on those dreaming of turning back the clock on their bodies. Studies on reversing age have mostly focused on aging mice — not humans — and Popular Science says research on humans will be necessary to see promise in this field.

Which billionaire is trying to reverse aging?

While not a billionaire, Tech CEO Bryan Johnson is reportedly spending up to US$2 million per year on medical tests and various procedures aimed at reversing his body’s natural aging process. However, longevity experts don’t think he has discovered the proverbial fountain of youth.

What is the latest anti-aging cell technology?

The latest anti-aging cell therapy uses CAR-T cells, a type of white blood cell that help bolster the immune system. CAR stands for chimeric antigen receptor and researchers believe that they can reprogram these cells to become cancer killers or even reverse cellular aging.

Securities Disclosure: I, Melissa Pistilli, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Rimfire Pacific Mining (ASX: RIM, “Rimfire”) is pleased to announce a maiden scandium Mineral Resource estimate for the Melrose and the northern portion of the Murga area (“Murga North”) prospects, together with an additional Exploration Target for the broader Murga area (excluding Murga North) which are located at Fifield 70 kilometres northwest of Parkes in central NSW (Figure 1).

Highlights

Maiden Scandium (Sc) Mineral Resources estimated for the Melrose and the northern portion of the Murga area (“Murga North”) comprising;3Mt @ 240 ppm Sc (1,120t Sc Oxide) Indicated and Inferred Mineral Resource at Melrose21Mt @ 125 ppm Sc (4,050t Sc Oxide) Inferred Mineral Resource at Murga North which is open to the south and westSignificant upside demonstrated by an Exploration Target for the broader Murga area and pipeline of satellite scandium prospectsInfill aircore (on 50m x 50m centres) and diamond drilling planned to upgrade Murga North Mineral ResourceAircore drilling (on 100m x 100m centres) planned to potentially convert the Exploration Target into a Mineral ResourcePlanned drilling commencing October 2024 fully funded by Rimfire’s exploration partner – GPR

Commenting on the announcement, Rimfire’s Managing Director Mr David Hutton said: “Declaring maiden Scandium Mineral Resources for Melrose and Murga North is an important first step in achieving our objective of building a globally significant scandium resource inventory at Fifield.

An accompanying Exploration Target for the broader Murga area also highlights the excellent potential to build upon the maiden Mineral Resources (See Cautionary Statement below)”.

Cautionary Statement: The potential quantity and grade of the Exploration Target is conceptual in nature and there has been insufficient exploration to estimate a Mineral Resource, and it is uncertain if further exploration will result in the estimation of a Mineral Resource.

Resource Estimate Details

H&S Consultants Pty Ltd (HSC) were engaged by Rimfire to undertake a Mineral Resource Estimate for the Melrose and Murga North Scandium Prospects. The Mineral Resources are reported in accordance with the 2012 JORC Code and Guidelines using a 100ppm scandium cutoff grade (see Tables 1 – 2).

Material Information Used to estimate the Mineral Resources is given in Appendix One and Table 1 (Sections 1 to 3) of this ASX Announcement.

In addition, HSC also defined an Exploration Target for the broader Murga area (excluding the Murga North Mineral Resource).

It is based on an outline of the scandium-bearing pyroxenite interpreted from aeromagnetic data and results of Rimfire’s 2024 reconnaissance aircore drilling (on nominal 400m x 400m centres) throughout the Murga area.

The boundaries of the Exploration Target are shown in Figure 4 and an average thickness of 15 metres has been assumed along with a default density of 2.15t/m3. However, it is unknown at this stage if the whole outlined area will have reasonable prospects for eventual extraction so it has been assumed that only 50% of the area within the pyroxenite outline will be classified as the Exploration Target.

The Exploration Target for the broader Murga area is: 100 to 200Mt at 100 to 200ppm Sc

Cautionary Statement: The potential quantity and grade of the Exploration Target is conceptual in nature and there has been insufficient exploration to estimate a Mineral Resource, and it is uncertain if further exploration will result in the estimation of a Mineral Resource.

Click here for the Investor Presentation

Click here for the full ASX Release

This post appeared first on investingnews.com